DIANE PURPER OUAKIL
Diane Purper-Ouakil is a Professor of child and adolescent psychiatry at the University Hospital of Montpellier, France. She has been head of the child and adolescent unit of the Saint Eloi Hospital since 2011. This unit has inpatient and outpatient care facilities for young patients with different mental health conditions and has specialized services for ADHD, trauma-related and eating disorders.
Diane Purper-Ouakil is the president of the newly founded French Society of ADHD, an organisation for health professionals involved in clinical practice, optimisation of care trajectories and research. She has recently joined the steering committee of Eunethydis and is also the co-lead of the ECNP child and adolescent network.
Diane Purper-Ouakil aims to develop the evidence base of psychological, neurophysiological and pharmacological treatments, especially for children and adolescents with challenging and enduring behavioural and emotional symptoms. She is involved in treatment studies assessing several types of interventions. Her current research focuses on parent programs, innovations in healthcare trajectories, and digital interventions, that can contribute to comprehensive treatment plans for young people with complex needs.
Diane Purper-Ouakil is the president of the newly founded French Society of ADHD, an organisation for health professionals involved in clinical practice, optimisation of care trajectories and research. She has recently joined the steering committee of Eunethydis and is also the co-lead of the ECNP child and adolescent network.
Diane Purper-Ouakil aims to develop the evidence base of psychological, neurophysiological and pharmacological treatments, especially for children and adolescents with challenging and enduring behavioural and emotional symptoms. She is involved in treatment studies assessing several types of interventions. Her current research focuses on parent programs, innovations in healthcare trajectories, and digital interventions, that can contribute to comprehensive treatment plans for young people with complex needs.
Check the activity agenda
Wednesday, May 22, 2024
• | Room 12 |
14:00-15:30
SYMPOSIUM: TRANSITION FROM CAMHS TO AMHS FOR YOUTH WITH NEURODEVELOPMENTAL DISORDERS: CHALLENGES AND ACTUAL ACHIEVEMENTS
Chair: Georgieff Nicolas (Outro País)
Speaker: Simone Pietro Marchini (Outro País)
Speaker: Diane Purper Ouakil (France)
Speaker: Joana Maria Figueiredo Oliveira Reis (Outro País)
Friday, May 24, 2024
• | Room 02 |
08:30-10:00
PLENARY SESSION: RECENT ADVANCES ON ADHD TREATMENT
Treatment of ADHD : from evidence synthesis to dissemination platforms
Addressing stigma and social representations of ADHD
What the Covid-19 Pandemic Taught Us About Delivering Personalized ADHD Treatment
Discussion
Coordinator: Mario Valdivia (Outro País)
Treatment of ADHD : from evidence synthesis to dissemination platforms
Speaker: Samuele Cortese (Outro País)
Addressing stigma and social representations of ADHD
Speaker: Diane Purper Ouakil (France)
What the Covid-19 Pandemic Taught Us About Delivering Personalized ADHD Treatment
Speaker: Mark Stein (Outro País)
Discussion
Organised by:
Promoted by:
Management:
OFFICIAL TOURISM AGENCY:
GOLD SPONSOR
BRONZE SPONSOR
